These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32437024)

  • 1. Convalescent plasma therapy: A passive therapy for an aggressive COVID-19.
    Sahu KK; Jindal V; Siddiqui AD; Cerny J; Gerber JM
    J Med Virol; 2020 Nov; 92(11):2251-2253. PubMed ID: 32437024
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful Convalescent Plasma Therapy in a Child With Severe Coronavirus Disease.
    Das SS; Chaudhuri K; Biswas RN
    Indian Pediatr; 2021 Jan; 58(1):89-90. PubMed ID: 33257603
    [No Abstract]   [Full Text] [Related]  

  • 3. Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19).
    Alghamdi AN; Abdel-Moneim AS
    Front Public Health; 2020; 8():437. PubMed ID: 32903641
    [No Abstract]   [Full Text] [Related]  

  • 4. Convalescent plasma for COVID-19 - encouraging signals of efficacy.
    Casadevall A; Tobian AAR
    Br J Haematol; 2021 Feb; 192(4):681-682. PubMed ID: 33524158
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19: Herd immunity and convalescent plasma transfer therapy.
    Syal K
    J Med Virol; 2020 Sep; 92(9):1380-1382. PubMed ID: 32281679
    [No Abstract]   [Full Text] [Related]  

  • 6. Convalescent plasma to treat COVID-19: clinical experience and efficacy.
    Pei S; Yuan X; Zhang Z; Yao R; Xie Y; Shen M; Li B; Chen X; Yin M
    Aging (Albany NY); 2021 Mar; 13(6):7758-7766. PubMed ID: 33735836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convalescent plasma to treat COVID-19: Following the Argentinian lead.
    Tiberghien P; Toussirot E; Richard P; Morel P; Garraud O
    Transfus Apher Sci; 2021 Jun; 60(3):103161. PubMed ID: 34045121
    [No Abstract]   [Full Text] [Related]  

  • 8. Convalescent plasma for COVID-19 considerations.
    Adiwinata Pawitan J
    Transfus Apher Sci; 2021 Feb; 60(1):102927. PubMed ID: 32878733
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is convalescent plasma an alternative treatment for Covid-19 patients?].
    Trejo-Gómor JE; Dimas-González J; Lagunas-Martínez A
    Salud Publica Mex; 2020; 62(6):870-871. PubMed ID: 33620985
    [No Abstract]   [Full Text] [Related]  

  • 10. A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma.
    Einollahi B; Cegolon L; Abolghasemi H; Imanizadeh S; Bahramifar A; Zhao S; Jafari R; Javanbakht M
    Transfus Apher Sci; 2020 Dec; 59(6):102995. PubMed ID: 33183986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thinking more about therapy with convalescent plasma for COVID-19 patients.
    Han G; Zhou YH
    Hum Vaccin Immunother; 2020 Nov; 16(11):2601-2603. PubMed ID: 32643512
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk-benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19.
    Dhanasekaran S; Vajravelu LK; Venkatesalu V
    Postgrad Med J; 2021 Jul; 97(1149):467-468. PubMed ID: 32817576
    [No Abstract]   [Full Text] [Related]  

  • 13. Convalescent Plasma for Covid-19.
    Joyner MJ; Pirofski LA
    N Engl J Med; 2022 Sep; 387(10):955. PubMed ID: 36069882
    [No Abstract]   [Full Text] [Related]  

  • 14. Convalescent Plasma for Covid-19.
    Paneth N
    N Engl J Med; 2022 Sep; 387(10):955. PubMed ID: 36069883
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
    Casadevall A; Joyner MJ; Pirofski LA
    Clin Infect Dis; 2021 Aug; 73(3):e540-e542. PubMed ID: 32805024
    [No Abstract]   [Full Text] [Related]  

  • 16. Once Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor.
    Rubin R
    JAMA; 2022 Mar; 327(12):1115-1116. PubMed ID: 35262639
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of immunocompromised COVID-19 patients with convalescent plasma.
    Fung M; Nambiar A; Pandey S; Aldrich JM; Teraoka J; Freise C; Roberts J; Chandran S; Hays SR; Bainbridge E; DeVoe C; Roque Gardner A; Yokoe D; Henrich TJ; Babik JM; Chin-Hong P
    Transpl Infect Dis; 2021 Apr; 23(2):e13477. PubMed ID: 32989856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.
    Estcourt L; Callum J
    N Engl J Med; 2022 May; 386(18):1753-1754. PubMed ID: 35507487
    [No Abstract]   [Full Text] [Related]  

  • 19. [Convalescent plasma therapy in COVID-19 patients].
    Ascencios L; Casa L
    Medicina (B Aires); 2021; 81(2):306. PubMed ID: 33906156
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 convalescent plasma therapy and immunodeficiency.
    Mungmunpuntipantip R; Wiwanitkit V
    Transfus Clin Biol; 2021 Aug; 28(3):306-307. PubMed ID: 34116917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.